Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Has Gained 4.55% This Week?

Tuesday, December 05, 2023 12:48 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Has Gained 4.55% This Week?

GT Biopharma Inc (GTBP) is around the middle of the Biotechnology industry according to InvestorsObserver. GTBP received an overall rating of 41, which means that it scores higher than 41 percent of all stocks. GT Biopharma Inc also achieved a score of 43 in the Biotechnology industry, putting it above 43 percent of Biotechnology stocks. Biotechnology is ranked 50 out of the 148 industries.

GTBP has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on GTBP!

See Full GTBP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 41 would rank higher than 41 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With GT Biopharma Inc Stock Today?

GT Biopharma Inc (GTBP) stock is unchanged -1.58% while the S&P 500 is lower by -0.24% as of 12:40 PM on Tuesday, Dec 5. GTBP is unmoved $0.00 from the previous closing price of $0.23 on volume of 179,995 shares. Over the past year the S&P 500 has gained 14.01% while GTBP is lower by -83.69%. GTBP lost -$0.29 per share the over the last 12 months. Click Here to get the full Stock Report for GT Biopharma Inc stock.